Yellow fever virus
| Amiodarone | YFV | Non-competitive β-adrenergic inhibitor | Preclinical | — | Human (multiple) | |
| Amodiaquine | YFV | Methyltransferase inhibitor | Preclinical | — | Human HNMT | |
| Azauridine | YFV | Nucleoside analog | Preclinical | — | Viral RNA pol | |
| Brequinar | YFV | DHODH (DHODH) inhibitor | Preclinical | — | Human DHODH | |
| Cyclosporine | YFV | Calcineurin inhibitor; allows for inhibition of T cell activation | Preclinical | — | Human CYPs | |
| Favipiravir | YFV | Viral RNA polymerase inhibitor | Approved (other) | Japan | Viral RNA pol | |
| Galidesivir | YFV | RNA-dependent RNA polymerase (RdRp) inhibitor | Preclinical | — | Viral RNA pol | |
| Glycyrrhizin | YFV | 0 | Preclinical | — | Human TNF | |
| GS-441524 | YFV | nucleoside analog | Preclinical | — | Viral RNA pol | |
| Ivermectin | YFV | Importin ?/?-mediated nuclear import inhibitor | Preclinical | — | Human importin | |
| Mitoxantrone | YFV | Topoisomerase II inhibitor | Preclinical | — | Human topoisomerase | |
| Obatoclax | YFV | Bcl-2 family inhibitor | Preclinical | — | Human MCL1 | |
| Raloxifene | YFV | Selective estrogen receptor modulator | Preclinical | — | Human (multiple) | |
| Ribavirin | YFV | Nucleoside inhibitor; Guanosine (ribonucleic) analog | Approved (other) | Japan | Viral RNA pol | |
| Sofosbuvir | YFV | Nucleotide analog inhibitor of HCV NS5B RNA-dependent RNA polymerase | Approved (other) | JapanChina | Viral RNA pol |